Novonesis unveils the latest in nutritional biosolutions at first Capital Markets Day since merger

19 Jun 2024 — Novonesis held its first Capital Markets Day since the merger of Chr. Hansen and Novozymes. In London, UK, the full management team talked to investors, analysts and the media about the company’s biosolutions for F&B, human and planetary health, as well as ongoing R&D, operations, strategy and financials.